Dr. Karen Tedesco

Claim this profile

USO - New York Oncology Hematology

Studies Breast Cancer
6 reported clinical trials
14 drugs studied

Area of expertise

1Breast Cancer
Karen Tedesco has run 5 trials for Breast Cancer. Some of their research focus areas include:
HER2
Stage IV
lymph node

Affiliated Hospitals

Image of trial facility.
USO - New York Oncology Hematology
Image of trial facility.
New York Oncology Hematology PC - Albany

Clinical Trials Karen Tedesco is currently running

Image of trial facility.

Imlunestrant

for Early Breast Cancer

This trial is testing a new medication called imlunestrant to see if it works better than standard hormone treatments for certain breast cancer patients. The study focuses on patients with early-stage breast cancer that is estrogen receptor positive and HER2 negative, who have already been on hormone therapy for a period of time and are at high risk of their cancer returning. Imlunestrant works by blocking estrogen from helping cancer cells grow.
Recruiting2 awards Phase 36 criteria

More about Karen Tedesco

Clinical Trial Related7 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Karen Tedesco has experience with
  • Bintrafusp Alfa
  • Abemaciclib
  • Imlunestrant
  • Tamoxifen
  • Anastrozole
  • Letrozole
Breakdown of trials Karen Tedesco has run
Breast Cancer

Other Doctors you might be interested in

Rahul Ravilla, MDNew York Oncology Hematology, P.C.
Nischala AmmannagariNew York Oncology Hematology, P.C.
Makenzi EvangelistNew York Oncology Hematology, P.C

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Karen Tedesco specialize in?
Karen Tedesco focuses on Breast Cancer and other conditions. In particular, much of their work with Breast Cancer has involved HER2 patients, or patients who are Stage IV.
Is Karen Tedesco currently recruiting for clinical trials?
Yes, Karen Tedesco is currently recruiting for 1 clinical trial in Albany New York. If you're interested in participating, you should apply.
Are there any treatments that Karen Tedesco has studied deeply?
Yes, Karen Tedesco has studied treatments such as Bintrafusp alfa, Abemaciclib, Imlunestrant.
What is the best way to schedule an appointment with Karen Tedesco?
Apply for one of the trials that Karen Tedesco is conducting.
What is the office address of Karen Tedesco?
The office of Karen Tedesco is located at: USO - New York Oncology Hematology, Albany, New York 12206 United States. This is the address for their practice at the USO - New York Oncology Hematology.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top